148 related articles for article (PubMed ID: 28700674)
1. Effects of taurine on resting-state fMRI activity in spontaneously hypertensive rats.
Chen VC; Hsu TC; Chen LJ; Chou HC; Weng JC; Tzang BS
PLoS One; 2017; 12(7):e0181122. PubMed ID: 28700674
[TBL] [Abstract][Full Text] [Related]
2. Effects of taurine on striatal dopamine transporter expression and dopamine uptake in SHR rats.
Chen VC; Chiu CC; Chen LJ; Hsu TC; Tzang BS
Behav Brain Res; 2018 Aug; 348():219-226. PubMed ID: 29694913
[TBL] [Abstract][Full Text] [Related]
3. Nicotine-stimulated release of [3H]norepinephrine is reduced in the hippocampus of an animal model of attention-deficit/hyperactivity disorder, the spontaneously hypertensive rat.
Sterley TL; Howells FM; Russell VA
Brain Res; 2014 Jul; 1572():1-10. PubMed ID: 24833064
[TBL] [Abstract][Full Text] [Related]
4. Evidence for reduced tonic levels of GABA in the hippocampus of an animal model of ADHD, the spontaneously hypertensive rat.
Sterley TL; Howells FM; Russell VA
Brain Res; 2013 Dec; 1541():52-60. PubMed ID: 24161405
[TBL] [Abstract][Full Text] [Related]
5. Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat).
Howells FM; Russell VA
Brain Res; 2008 Mar; 1200():107-15. PubMed ID: 18295191
[TBL] [Abstract][Full Text] [Related]
6. N-methyl-D-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder.
Jensen V; Rinholm JE; Johansen TJ; Medin T; Storm-Mathisen J; Sagvolden T; Hvalby O; Bergersen LH
Neuroscience; 2009 Jan; 158(1):353-64. PubMed ID: 18571865
[TBL] [Abstract][Full Text] [Related]
7. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.
van den Bergh FS; Bloemarts E; Chan JS; Groenink L; Olivier B; Oosting RS
Pharmacol Biochem Behav; 2006 Mar; 83(3):380-90. PubMed ID: 16580713
[TBL] [Abstract][Full Text] [Related]
8. The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior.
Wultz B; Sagvolden T; Moser EI; Moser MB
Behav Neural Biol; 1990 Jan; 53(1):88-102. PubMed ID: 2302145
[TBL] [Abstract][Full Text] [Related]
9. Increased Oxidative Parameters and Decreased Cytokine Levels in an Animal Model of Attention-Deficit/Hyperactivity Disorder.
Leffa DT; Bellaver B; de Oliveira C; de Macedo IC; de Freitas JS; Grevet EH; Caumo W; Rohde LA; Quincozes-Santos A; Torres ILS
Neurochem Res; 2017 Nov; 42(11):3084-3092. PubMed ID: 28664398
[TBL] [Abstract][Full Text] [Related]
10. Quantitative regional cerebral blood flow MRI of animal model of attention-deficit/hyperactivity disorder.
Danker JF; Duong TQ
Brain Res; 2007 May; 1150():217-24. PubMed ID: 17391651
[TBL] [Abstract][Full Text] [Related]
11. Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar-Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.
Mc Fie S; Sterley TL; Howells FM; Russell VA
Brain Res; 2012 Jul; 1467():91-103. PubMed ID: 22658977
[TBL] [Abstract][Full Text] [Related]
12. Awake whole-brain functional connectivity alterations in the adolescent spontaneously hypertensive rat feature visual streams and striatal networks.
Poirier GL; Huang W; Tam K; DiFranza JR; King JA
Brain Struct Funct; 2017 May; 222(4):1673-1683. PubMed ID: 27680743
[TBL] [Abstract][Full Text] [Related]
13. Stimulus control in two rodent models of attention-deficit/hyperactivity disorder.
Fox AE; Caramia SR; Haskell MM; Ramey AL; Singha D
Behav Processes; 2017 Feb; 135():16-24. PubMed ID: 27864066
[TBL] [Abstract][Full Text] [Related]
14. Comparison of SHR, WKY and Wistar rats in different behavioural animal models: effect of dopamine D1 and alpha2 agonists.
Langen B; Dost R
Atten Defic Hyperact Disord; 2011 Mar; 3(1):1-12. PubMed ID: 21432613
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the validity of the use of the spontaneously hypertensive rat as a model of attention deficit hyperactivity disorder in males and females.
Bayless DW; Perez MC; Daniel JM
Behav Brain Res; 2015 Jun; 286():85-92. PubMed ID: 25724583
[TBL] [Abstract][Full Text] [Related]
16. Genetically determined differences in noradrenergic function: The spontaneously hypertensive rat model.
Sterley TL; Howells FM; Russell VA
Brain Res; 2016 Jun; 1641(Pt B):291-305. PubMed ID: 26612520
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.
Li Q; Lu G; Antonio GE; Mak YT; Rudd JA; Fan M; Yew DT
Neurochem Int; 2007 May; 50(6):848-57. PubMed ID: 17395336
[TBL] [Abstract][Full Text] [Related]
18. Adolescent methylphenidate treatment differentially alters adult impulsivity and hyperactivity in the Spontaneously Hypertensive Rat model of ADHD.
Somkuwar SS; Kantak KM; Bardo MT; Dwoskin LP
Pharmacol Biochem Behav; 2016 Feb; 141():66-77. PubMed ID: 26657171
[TBL] [Abstract][Full Text] [Related]
19. Homer expression in the hippocampus of an animal model of attention-deficit/hyperactivity disorder.
Hong Q; Wang YP; Zhang M; Pan XQ; Guo M; Li F; Tong ML; Chen RH; Guo XR; Chi X
Mol Med Rep; 2011; 4(4):705-12. PubMed ID: 21523321
[TBL] [Abstract][Full Text] [Related]
20. Dysfunction of myocardial and vascular taurine transport in spontaneously hypertensive rats.
Shi YR; Qi YF; Bu DF; Gao L; Wang DY; Jiang HF; Pang YZ; Tang CS
Sheng Li Xue Bao; 2002 Oct; 54(5):359-64. PubMed ID: 12399812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
